BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery

  title={BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery},
  author={R. Kombarov and Andrea Altieri and Dmitry Genis and Mikhail Kirpichenok and V. Kochubey and N. Rakitina and Zoya Titarenko},
  journal={Molecular Diversity},
  • R. Kombarov, Andrea Altieri, +4 authors Zoya Titarenko
  • Published 2009
  • Medicine, Chemistry
  • Molecular Diversity
  • The analysis of known drugs (Comprehensive Medicinal Chemistry database (2008 version): and natural products (Koch et al., Proc Natl Acad Sci USA 102:17272–17277, 2008) has led to the identification of privileged saturated and aromatic heterocyclic ring pairs that we have termed as “BioCores.” This article explains how the BioCores can be used for the design of novel lead-like scaffolds. 
    42 Citations

    Figures and Topics from this paper.

    Natural product-like synthetic libraries.
    • 64
    Smart Design of Small‐Molecule Libraries: When Organic Synthesis Meets Cheminformatics
    • E. Lenci, A. Trabocchi
    • Computer Science, Medicine
    • Chembiochem : a European journal of chemical biology
    • 2019
    • 1
    Toward an Efficient Approach to Identify Molecular Scaffolds Possessing Selective or Promiscuous Compounds
    • 4
    Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery.
    • 17
    Molecular Scaffold Analysis of Natural Products Databases in the Public Domain
    • 53


    Natural compounds as drugs
    • 24
    Charting biologically relevant chemical space: a structural classification of natural products (SCONP).
    • 429
    • PDF
    Novel chemical space exploration via natural products.
    • 198
    • PDF
    The role of natural product chemistry in drug discovery.
    • M. S. Butler
    • Medicine, Biology
    • Journal of natural products
    • 2004
    • 1,053
    • PDF
    The properties of known drugs. 1. Molecular frameworks.
    • 1,133
    Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening.
    • G. Rishton
    • Biology, Medicine
    • Current opinion in chemical biology
    • 2008
    • 39
    • Highly Influential
    Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection.
    • 66
    Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    • 81
    • PDF